PUBLICACIÓN
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy
Duarte J.D. et al.
2024 Clinical Pharmacology and Therapeutics
Pharmacology (Q1), Pharmacology (medical) (Q1)
JCR: 5.5
SJR: 2.127
CITAS
34
DOI
10.1002/cpt.3351
EID
2-s2.0-85197294153
ISSN
0009-9236
EISSN
1532-6535
BIBTEX
@article{Agundez2024,title = {Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC)~for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy},journal = {Clinical Pharmacology and Therapeutics},year = {2024},volume = {116},number = {4},pages = {939-947},author = {Duarte, J.D. and Thomas, C.D. and Lee, C.R. and Huddart, R. and Agundez, J.A.G. and Baye, J.F. and Gaedigk, A. and Klein, T.E. and Lanfear, D.E. and Monte, A.A. and Nagy, M. and Schwab, M. and Stein, C.M. and Uppugunduri, C.R.S. and van Schaik, R.H.N. and Donnelly, R.S. and Caudle, K.E. and Luzum, J.A.}}
AUTORES DE LA UEX
